Related Experiment Videos
A 3-dimensional tumor growth inhibition assay for testing monoclonal antibody cytotoxicity
Abstract:
A 3-dimensional tumor growth inhibition assay [18] has been adapted to test the cytotoxic activity of a panel of monoclonal antibodies directed to various antigenic determinants on the surface of mouse mammary tumor cells. Target cells can be prepared from either cultured cells or from pieces of fresh tumor. Antibody and complement are added when cells are growing actively and cell growth can be measured, non destructively, over a 7-10-day period. Effective diffusion of antibody through collagen gel and binding to target cells embedded in the gel is demonstrated by indirect immunofluorescent staining. The specificity of monoclonal antibody AMT 101 cytotoxicity for mouse mammary tumor cells is the same in trypan blue exclusion assays of single-cell suspensions as in collagen gel assays, with complete killing seen in the collagen gel assay only. The collagen gel assay allows the testing of repeated treatments in vitro, as well as combined treatment with multiple antibodies. It also allows cell-cell interaction and preserves all cell components in the tumor. The collagen gel assay has potential as a method of predicting the outcome of monoclonal antibody treatment of solid tumors.
Insights
A novel 3D collagen gel assay effectively measures monoclonal antibody cytotoxicity against mouse mammary tumors. This method preserves tumor structure, enabling prediction of treatment outcomes for solid tumors.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Monoclonal antibodies (mAbs) show promise in cancer therapy.
- Evaluating mAb efficacy against solid tumors requires robust in vitro models.
- Current assays may not fully represent the tumor microenvironment.
Purpose of the Study:
- To adapt a 3D tumor growth inhibition assay for testing mAb-mediated cytotoxicity.
- To assess the efficacy and specificity of mAbs against mouse mammary tumor cells in a 3D model.
- To evaluate the potential of this assay for predicting mAb treatment outcomes.
Main Methods:
- Adaptation of a 3D collagen gel assay for evaluating mAb cytotoxicity.
- Preparation of target cells from cultured cells or fresh tumors.
- Non-destructive measurement of cell growth over 7-10 days.
- Demonstration of antibody diffusion and binding using indirect immunofluorescence.
- Comparison with trypan blue exclusion assays for cytotoxicity assessment.
Main Results:
- The 3D collagen gel assay effectively measures mAb cytotoxicity against mouse mammary tumor cells.
- Antibody diffusion and binding within the gel were confirmed.
- Complete tumor cell killing was observed in the collagen gel assay.
- The assay preserves cell-cell interactions and tumor components.
- Results correlated with single-cell suspension assays but offered enhanced sensitivity.
Conclusions:
- The adapted 3D collagen gel assay is a viable method for assessing mAb cytotoxicity.
- This assay provides a more biologically relevant model for solid tumors compared to traditional methods.
- The 3D assay has potential for predicting the clinical efficacy of monoclonal antibody therapy for solid tumors.